Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Oct 30;8(1):239.
doi: 10.1038/s41398-018-0283-7.

Subclinical hypothyroidism and depression: a meta-analysis

Affiliations
Meta-Analysis

Subclinical hypothyroidism and depression: a meta-analysis

T Zhao et al. Transl Psychiatry. .

Abstract

The objective of this study was to evaluate the relationship between subclinical hypothyroidism (SCH) and depression. We also analysed the effect of levothyroxine (L-T4) on depression in SCH patients. We found an insignificant difference for the composite endpoint: standard mean difference (SMD) of 0.23 (95% confidence interval (CI) -0.03, 0.48, P = 0.08, I2 = 73.6%). The odds ratio (OR) for depressive patients was 1.75 (95% CI 0.97, 3.17 P = 0.064, I2 = 64.6%). Furthermore, sub-group analysis according to age found that SCH was related to depression in younger patients (<60 years old), as defined by the diagnosis of depression: OR of 3.8 (95% CI 1.02, 14.18, P = 0.047, I2 = 0.0%) or an increase on the depressive scale: SMD of 0.42 (95% CI 0.03, 0.82, P = 0.036, I2 = 66.6%). Meanwhile, SCH did not associate with depression in older patients (≥60 years old), as defined by the diagnosis of depression: OR of 1.53 (95% CI 0.81, 2.90, P = 0.193, I2 = 71.3%) or an increase on the depressive scale: SMD of 0.03 (95%CI -0.31, 0.37, P = 0.857, I2 = 79.8%). We also found an insignificant difference in the composite endpoint between the L-T4 supplementation group and placebo group in SCH patients. The estimated SMD was 0.26 (95% CI -0.09, 0.62, P = 0.143, I2 = 52.9%). This meta-analysis demonstrates that SCH is not connected to depression. However, sub-group analysis according to age found that SCH is related to depression in younger patients, but not in older patients. Furthermore, we failed to find an effect of L-T4 supplementation treatment for SCH on depression.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
a Forest plots showing standard mean differences (SMD, 95% CI) for the increase of depressive score in SCH patients comparing to the normal individuals in a random effects model. X-axis: possitive values equal to the aggravation on depressive tendency. b Subgroup analyses of depressive scale based on age in a random effects model. X-axis: possitive values equal to the aggravation on depressive tendency. SMD: standard mean differences. Younger: participants with the mean age <60 years old. Older: participants with the mean or minimum age ≥60 years old
Fig. 2
Fig. 2
a Forest plots of studies comparing the number of depression patients between SCH and euthyroid individuals. The rhombus represents the OR and 95% CI obtained for the combined calculation. b Subgroup analyses of depression based on age in a random effects model. The rhombus represents the OR and 95% CI obtained for the combined calculation. Younger: participants with the mean age <60 years old. Older: participants with the mean or minimum age ≥60 years old
Fig. 3
Fig. 3
Forest plots showing standard mean differences (SMD, 95% CI) for improvement in depressive scale comparing L-T4 treatment to the placebo group in a random effects model. X-axis: positive values equal to the aggravation on depressive tendency

References

    1. Rack SK, Makela EH. Hypothyroidism and depression: a therapeutic challenge. Ann. Pharmacother. 2000;34:1142–1145. doi: 10.1345/aph.10022. - DOI - PubMed
    1. Whybrow PC, Prange AJ, Jr, Treadway CR. Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch. General Psychiatry. 1969;20:48–63. doi: 10.1001/archpsyc.1969.01740130050004. - DOI - PubMed
    1. Shan Z, et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid. 2016;26:1125–1130. doi: 10.1089/thy.2015.0613. - DOI - PubMed
    1. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch. Intern. Med. 1985;145:1386–1388. doi: 10.1001/archinte.1985.00360080056006. - DOI - PubMed
    1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000;160:526–534. doi: 10.1001/archinte.160.4.526. - DOI - PubMed

Publication types